Morphology and tumour‐infiltrating lymphocytes in high‐stage, high‐grade serous ovarian carcinoma correlated with long‐term survival
- 14 July 2018
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 73 (6) , 1002-1012
Abstract
Aims: Advanced‐stage ovarian high‐grade serous carcinoma (HGSC) is a poor‐prognosis cancer; however, a small and poorly characterised subset of patients shows long‐term survival. We aimed to establish a cohort of HGSC long‐term survivors for histopathological and molecular analysis.Methods and results: Paraffin blocks from 151 patients with primary FIGO III/IV HGSC and progression‐free survival (PFS) >5 years were collected within the Tumorbank Ovarian Cancer (TOC) Network; 77 HGSC with a PFS + and CD8+ TILs and were more frequently positive for MHC2 than controls (P = 0.004, P = 0.025, P = 0.048). However, there were also long‐term survivors (up to 20%) with low TILs or low MHC expression. TILs and MHC had no impact on survival in long‐term survivors. Morphological and Ki67 analysis revealed no differences between long‐term survivors and controls.Conclusions: HGSC from long‐term survivors have higher‐level T cell infiltration and antigen‐presentation capacity; however, this is not a prerequisite for an excellent prognosis. Histopathological criteria are not capable to identify these patients. Further extensive clinical and molecular characterisation of this enigmatic subgroup is ongoing to understand the reasons of long‐term survival in HGSC.Keywords
Funding Information
- Charité – Universitätsmedizin Berlin
This publication has 30 references indexed in Scilit:
- CognitionMaster: an object-based image analysis frameworkDiagnostic Pathology, 2013
- BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaLaboratory Investigation, 2012
- Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IVInternational Journal of Gynecological Cancer, 2012
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysisGynecologic Oncology, 2012
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian CancerJAMA, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Maximal cytoreductive effort in epithelial ovarian cancer surgeryJournal of Gynecologic Oncology, 2010
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossLaboratory Investigation, 2009
- Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancerJournal of Gynecologic Oncology, 2008
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI: Journal of the National Cancer Institute, 2000